Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Abstract 4254: Development of DEM201, a blocking antibody against SMAGP, a novel “Don′t Eat Me” signal overexpressed in cancer

Sarah E. Carden, Agnieszka Denslow, Mary Baumel, Jing Zhu, Lissette Garcia, Sarah Nesti, Kayla Belanger, Meghan Davis, Carmen Adriaens, Sandeep Kumar, Christophe Quéva, Loise Francisco

Cancer Res (2025) 85 (8_Supplement_1): 4254.

https://doi.org/10.1158/1538-7445.AM2025-4254

Published: 21 April 2025

View articletitled, Abstract 4254: Development of DEM201, a blocking antibody against SMAGP, a novel “Don′t Eat Me” signal overexpressed in cancer

Journal Articles

Abstract PS12-08: MORPHEUS Hormone Receptor-Positive Breast Cancer: interim analysis of a Phase Ib/II, study of fulvestrant ± atezolizumab and abemaciclib triplet treatment in patients metastatic disease

Kyung Hae Jung, Seock-Ah Im, Denise Yardley, Sara Hurvitz, Keun Seok Lee, Amir Sonnenblick, Shlomit Shachar, Antoinette Tan, Elizabeth Comen, Einav Gal-Yam, Adam Brufsky, Hope Rugo, Jing Zhu, Kelly DuPree, Vanessa Breton, Fiona Young, Richard Schwab, Edward Cha, Melinda Telli

Cancer Res (2024) 84 (9_Supplement): PS12-08.

https://doi.org/10.1158/1538-7445.SABCS23-PS12-08

Published: 02 May 2024

View articletitled, Abstract PS12-08: MORPHEUS Hormone Receptor-Positive Breast Cancer: interim analysis of a Phase Ib/II, study of fulvestrant ± atezolizumab and abemaciclib triplet treatment in patients metastatic disease

Journal Articles

Abstract PS17-07: Interim analysis of giredestrant + inavolisib in MORPHEUS Breast Cancer: a Phase Ib/II study of giredestrant treatment combinations in estrogen receptor-positive, HER2-negative, locally advanced/metastatic breast cancer

Hope Rugo, Maria Gion, Cristina Hernando, Kyung Hae Jung, Mafalda Oliveira, Melinda Telli, Gregory Vidal, Sina Vatandoust, Jing Zhu, Richard Schwab, Huy Ngo, Erika Ferreira, Ann Collier, Vanessa Breton, Einav Gal-Yam

Cancer Res (2024) 84 (9_Supplement): PS17-07.

https://doi.org/10.1158/1538-7445.SABCS23-PS17-07

Published: 02 May 2024

View articletitled, Abstract PS17-07: Interim analysis of giredestrant + inavolisib in MORPHEUS Breast Cancer: a Phase Ib/II study of giredestrant treatment combinations in estrogen receptor-positive, HER2-negative, locally advanced/metastatic breast cancer

Journal Articles

Hydrogen Sulfide Creates a Favorable Immune Microenvironment for Colon Cancer

Taohua Yue, Jichang Li, Jing Zhu, Shuai Zuo, Xin Wang, Yucun Liu, Jia Liu, Xiaoyun Liu, Pengyuan Wang, Shanwen Chen

Cancer Res (2023) 83 (4): 595–612.

https://doi.org/10.1158/0008-5472.CAN-22-1837

Published: 15 February 2023

View articletitled, Hydrogen Sulfide Creates a Favorable Immune Microenvironment for Colon Cancer

Includes: Supplementary data

Journal Articles

Abstract PD10-04: Phase Ib/II open-label, randomized trial of atezolizumab (atezo) with ipatasertib (ipat) and fulvestrant (fulv) vs control in MORPHEUS-HR+ breast cancer (M-HR+ BC) and atezo with ipat vs control in MORPHEUS triple negative breast cancer (M-TNBC)

Sara A. Hurvitz, Valentina Boni, Elizabeth Comen, Seock-Ah Im, Kyung Hae Jung, Sung-Bae Kim, Keun Seok Lee, Sherene Loi, Hope S. Rugo, Amir Sonnenblick, Melinda L. Telli, Kelly DuPree, Marcella Fasso, Ya-Chen Lin, Mina Nikanjam, Frauke Schimmoller, Xiaosong Zhang, Jing Zhu, Peter Schmid

Cancer Res (2022) 82 (4_Supplement): PD10-04.

https://doi.org/10.1158/1538-7445.SABCS21-PD10-04

Published: 15 February 2022

View articletitled, Abstract PD10-04: Phase Ib/II open-label, randomized trial of atezolizumab (atezo) with ipatasertib (ipat) and fulvestrant (fulv) vs control in MORPHEUS-HR+ breast cancer (M-HR+ BC) and atezo with ipat vs control in MORPHEUS triple negative breast cancer (M-TNBC)

Journal Articles

Abstract PS11-13: Multidimensional molecular profiling of repeated metastatic TNBC biopsies in the intensive trial of omics <ITOMIC> safely guides treatment decisions

Kimberly A Burton, Eric Q Konnick, Sibel Blau, Michael O Dorschner, Julie Gralow, Rahul Parulkar, Elisabeth Mahen, Patricia Spilman, Stephanie Parker, Francis M Senecal, Colin Pritchard, Christopher Szeto, Jing Zhu, Vijayakrishna K Gadi, Stephen C Benz, Shahrooz Rabizadeh, Patrick Soon-Shiong, Carl Anthony Blau

Cancer Res (2021) 81 (4_Supplement): PS11-13.

https://doi.org/10.1158/1538-7445.SABCS20-PS11-13

Published: 15 February 2021

View articletitled, Abstract PS11-13: Multidimensional molecular profiling of repeated metastatic TNBC biopsies in the intensive trial of omics &lt;ITOMIC&gt; safely guides treatment decisions

Journal Articles

Abstract 3536: Advantages of ssDNA over dsDNA library preparation for capturing cell-free tumor DNA in plasma

Jing Zhu, Jingyong Huang, Peng Zhang, Manish Kohli, Chiang-Ching Huang, Liang Wang

Cancer Res (2019) 79 (13_Supplement): 3536.

https://doi.org/10.1158/1538-7445.AM2019-3536

Published: 01 July 2019

View articletitled, Abstract 3536: Advantages of ssDNA over dsDNA library preparation for capturing cell-free tumor DNA in plasma

Journal Articles

Abstract 1280: Functional characterization of prostate cancer risk loci by SNPs-seq and STARR-seq

Peng Zhang, Jing Zhu, Sufyan Suleman, Yong-Chen Guo, Mei-Jun Du, Li-Dong Wang, Gong-Hong Wei, Liang Wang

Cancer Res (2017) 77 (13_Supplement): 1280.

https://doi.org/10.1158/1538-7445.AM2017-1280

Published: 01 July 2017

View articletitled, Abstract 1280: Functional characterization of prostate cancer risk loci by SNPs-seq and STARR-seq

Journal Articles

Abstract 4244: Detection and characterization of extrachromosomal circular DNA in human plasma

Jing Zhu, Meijun Du, Peng Zhang, Liang Wang

Cancer Res (2017) 77 (13_Supplement): 4244.

https://doi.org/10.1158/1538-7445.AM2017-4244

Published: 01 July 2017

View articletitled, Abstract 4244: Detection and characterization of extrachromosomal circular DNA in human plasma

Journal Articles

Abstract 4919: Evaluating the gene expression of frozen tissue-derived prognostic signatures in FFPE colorectal cancer samples

Jing Zhu, Natasha G. Deane, Keeli B. Lewis, Chandrasekhar Padmanabhan, Mary K. Washington, Kristen K. Ciombor, Cynthia Timmers, Richard M. Goldberg, R. Daniel Beauchamp, Xi Chen

Cancer Res (2016) 76 (14_Supplement): 4919.

https://doi.org/10.1158/1538-7445.AM2016-4919

Published: 15 July 2016

View articletitled, Abstract 4919: Evaluating the gene expression of frozen tissue-derived prognostic signatures in FFPE colorectal cancer samples

Journal Articles

Abstract 3421: Comparing gene expression of matched FFPE colorectal cancer samples measured by Nanostring nCounter® platform and Affymetrix GeneChip® Human Transcriptome Array platform

Jing Zhu, Natasha G. Deane, Keeli B. Lewis, Mary K. Washington, Xi Chen, Robert D. Beauchamp

Cancer Res (2015) 75 (15_Supplement): 3421.

https://doi.org/10.1158/1538-7445.AM2015-3421

Published: 01 August 2015

View articletitled, Abstract 3421: Comparing gene expression of matched FFPE colorectal cancer samples measured by Nanostring nCounter® platform and Affymetrix GeneChip® Human Transcriptome Array platform

Journal Articles

Abstract 4097: Small molecule mediated transcriptional derepression of E-cadherin and inhibition of epithelial to mesenchymal transition

Hanbing An, Natasha Deane, Sydney Stoops, Jing Zhu, Alex Waterson, Andries Zijlstra, Craig Lindsley, Robert Daniel Beauchamp

Cancer Res (2015) 75 (15_Supplement): 4097.

https://doi.org/10.1158/1538-7445.AM2015-4097

Published: 01 August 2015

View articletitled, Abstract 4097: Small molecule mediated transcriptional derepression of E-cadherin and inhibition of epithelial to mesenchymal transition

Journal Articles

Nuclear Factor of Activated T-cell Activity Is Associated with Metastatic Capacity in Colon Cancer

Manish K. Tripathi, Natasha G. Deane, Jing Zhu, Hanbing An, Shinji Mima, Xiaojing Wang, Sekhar Padmanabhan, Zhiao Shi, Naresh Prodduturi, Kristen K. Ciombor, Xi Chen, M. Kay Washington, Bing Zhang, R. Daniel Beauchamp

Cancer Res (2014) 74 (23): 6947–6957.

https://doi.org/10.1158/0008-5472.CAN-14-1592

Published: 30 November 2014

View articletitled, Nuclear Factor of Activated T-cell Activity Is Associated with Metastatic Capacity in Colon Cancer

Includes: Supplementary data

Journal Articles

Abstract 921: Liposomal bortezomib improves chemosensitivity and inhibits cell proliferation in part through BCR/ABL downregulation in CML

Xiaojuan Yang, Mengzi Zhang, Yong Peng, Heng Liu, Jing Zhu, Jiuxia Pang, Robert J. Lee, Shujun Liu

Cancer Res (2012) 72 (8_Supplement): 921.

https://doi.org/10.1158/1538-7445.AM2012-921

Published: 15 April 2012

View articletitled, Abstract 921: Liposomal bortezomib improves chemosensitivity and inhibits cell proliferation in part through BCR/ABL downregulation in CML

Journal Articles

Abstract 2985: Predicting the impact of mutations in cancer using an integrated pathway approach

Sam Ng, Janita Thusberg, Stephen Benz, Charles Vaske, Kyle Ellrott, Jing Zhu, Christina Yau, Eric Collisson, Sean Mooney, Christopher Benz, David Haussler, Joshua Stuart

Cancer Res (2012) 72 (8_Supplement): 2985.

https://doi.org/10.1158/1538-7445.AM2012-2985

Published: 15 April 2012

View articletitled, Abstract 2985: Predicting the impact of mutations in cancer using an integrated pathway approach

Journal Articles

Abstract 4905: Patient-specific pathway analysis using PARADIGM identifies key activities in multiple cancers

Stephen C. Benz, Charles Vaske, Sam Ng, John Zachary Sanborn, Jing Zhu, David Haussler, Joshua Stuart

Cancer Res (2011) 71 (8_Supplement): 4905.

https://doi.org/10.1158/1538-7445.AM2011-4905

Published: 15 April 2011

View articletitled, Abstract 4905: Patient-specific pathway analysis using PARADIGM identifies key activities in multiple cancers

Journal Articles

Abstract 2001: Non-negative matrix factorization (NMF) as a clinical classifier: An example with chemotherapy response in ovarian cancer

Szeto Christopher, Stephen Benz, Charles Vaske, J. Zachary Sanborn, Jing Zhu, Joshua Stuart, David Haussler

Cancer Res (2010) 70 (8_Supplement): 2001.

https://doi.org/10.1158/1538-7445.AM10-2001

Published: 15 April 2010

View articletitled, Abstract 2001: Non-negative matrix factorization (NMF) as a clinical classifier: An example with chemotherapy response in ovarian cancer

Journal Articles

Abstract #2462: UCSC BioIntegrator: A multi-platform analysis pipeline

J. Sanborn, Stephen Benz, Jing Zhu, Christopher Szeto, Ting Wang, David Haussler

Cancer Res (2009) 69 (9_Supplement): 2462.

Published: 01 May 2009

View articletitled, Abstract #2462: UCSC BioIntegrator: A multi-platform analysis pipeline

Journal Articles

Detection of surface molecules and phosphorylation events by surface enhanced raman scattering (SERS) using composite organic-inorganic nanoparticles (COINs) in single cells.

Catherine Shachaf, Sailaja Elchuri, Jing Zhu, Lienchi Nguyen, Jingwu Zhang, Lei Sun, Salena Chang, Garry Nolan

Cancer Res (2008) 68 (9_Supplement): 4742.

Published: 01 May 2008

View articletitled, Detection of surface molecules and phosphorylation events by surface enhanced raman scattering (SERS) using composite organic-inorganic nanoparticles (COINs) in single cells.

Journal Articles

Cyclin D1b influences breast cancer cell growth through antagonizing cyclin D1a mediated estrogen receptor alpha activity

Jing Zhu, Marsha Frazier

Cancer Res (2008) 68 (9_Supplement): 4226.

Published: 01 May 2008

View articletitled, Cyclin D1b influences breast cancer cell growth through antagonizing cyclin D1a mediated estrogen receptor alpha activity

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 4254: Development of DEM201, a blocking antibody against SMAGP, a novel “Don′t Eat Me” signal overexpressed in cancer

Abstract PS12-08: MORPHEUS Hormone Receptor-Positive Breast Cancer: interim analysis of a Phase Ib/II, study of fulvestrant ± atezolizumab and abemaciclib triplet treatment in patients metastatic disease

Abstract PS17-07: Interim analysis of giredestrant + inavolisib in MORPHEUS Breast Cancer: a Phase Ib/II study of giredestrant treatment combinations in estrogen receptor-positive, HER2-negative, locally advanced/metastatic breast cancer

Hydrogen Sulfide Creates a Favorable Immune Microenvironment for Colon Cancer

Abstract PD10-04: Phase Ib/II open-label, randomized trial of atezolizumab (atezo) with ipatasertib (ipat) and fulvestrant (fulv) vs control in MORPHEUS-HR+ breast cancer (M-HR+ BC) and atezo with ipat vs control in MORPHEUS triple negative breast cancer (M-TNBC)

Abstract PS11-13: Multidimensional molecular profiling of repeated metastatic TNBC biopsies in the intensive trial of omics <ITOMIC> safely guides treatment decisions

Abstract 3536: Advantages of ssDNA over dsDNA library preparation for capturing cell-free tumor DNA in plasma

Abstract 1280: Functional characterization of prostate cancer risk loci by SNPs-seq and STARR-seq

Abstract 4244: Detection and characterization of extrachromosomal circular DNA in human plasma

Abstract 4919: Evaluating the gene expression of frozen tissue-derived prognostic signatures in FFPE colorectal cancer samples

Abstract 3421: Comparing gene expression of matched FFPE colorectal cancer samples measured by Nanostring nCounter® platform and Affymetrix GeneChip® Human Transcriptome Array platform

Abstract 4097: Small molecule mediated transcriptional derepression of E-cadherin and inhibition of epithelial to mesenchymal transition

Nuclear Factor of Activated T-cell Activity Is Associated with Metastatic Capacity in Colon Cancer

Abstract 921: Liposomal bortezomib improves chemosensitivity and inhibits cell proliferation in part through BCR/ABL downregulation in CML

Abstract 2985: Predicting the impact of mutations in cancer using an integrated pathway approach

Abstract 4905: Patient-specific pathway analysis using PARADIGM identifies key activities in multiple cancers

Abstract 2001: Non-negative matrix factorization (NMF) as a clinical classifier: An example with chemotherapy response in ovarian cancer

Abstract #2462: UCSC BioIntegrator: A multi-platform analysis pipeline

Detection of surface molecules and phosphorylation events by surface enhanced raman scattering (SERS) using composite organic-inorganic nanoparticles (COINs) in single cells.

Cyclin D1b influences breast cancer cell growth through antagonizing cyclin D1a mediated estrogen receptor alpha activity

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only